Last update Dec. 19, 2013


Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

Topical ophthalmologic anti-histaminic drug that achieves very low plasma concentration with only 60 pg/mL. Hence, an insignificant excretion into breast milk should be advanced.


We do not have alternatives for Alcaftadine since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.


Alcaftadine belongs to this group or family:


Main tradenames from several countries containing Alcaftadine in its composition:


Variable Value Unit
Molecular weight 307 daltons
Protein Binding 39 - 63 %
Tmax 0.25 hours
2 hours
Theoretical Dose < 0.00001 mg/Kg/d


  1. Bohets H, McGowan C, Mannens G, Schroeder N, Edwards-Swanson K, Shapiro A. Clinical pharmacology of alcaftadine, a novel antihistamine for the prevention of allergic conjunctivitis. J Ocul Pharmacol Ther. 2011 Abstract
  2. Alcaftadina. Ficha técnica. 2011 Full text (in our servers)
  3. Alcaftadine. Data Sheet. 2011 Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at

e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM